CN105617180A - Pure traditional Chinese medicine particles for treating pneumothorax - Google Patents

Pure traditional Chinese medicine particles for treating pneumothorax Download PDF

Info

Publication number
CN105617180A
CN105617180A CN201610137764.4A CN201610137764A CN105617180A CN 105617180 A CN105617180 A CN 105617180A CN 201610137764 A CN201610137764 A CN 201610137764A CN 105617180 A CN105617180 A CN 105617180A
Authority
CN
China
Prior art keywords
grams
chinese medicine
traditional chinese
pure traditional
medicine particles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610137764.4A
Other languages
Chinese (zh)
Inventor
刘湘秋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Changxing County Dongfang Traditional Chinese Medicine Research Institute
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201610137764.4A priority Critical patent/CN105617180A/en
Publication of CN105617180A publication Critical patent/CN105617180A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/34Campanulaceae (Bellflower family)
    • A61K36/344Codonopsis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/42Cucurbitaceae (Cucumber family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8965Asparagus, e.g. garden asparagus or asparagus fern
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8968Ophiopogon (Lilyturf)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/898Orchidaceae (Orchid family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/904Stemonaceae (Stemona family), e.g. croomia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses pure traditional Chinese medicine particles for treating pneumothorax. The pure traditional Chinese medicine particles for treating pneumothorax are prepared from, by weight, 240-260 g of lance asiabell roots, 140-160 g of radix ophiopogonis, 90-110 g of radix stemonae, 70-90 g of common bletilla tubers, 140-160 g of cochinchnese asparagus roots, 140-160 g of common cephalanoplos herb, 70-90 g of licorice roots and 50-70 g of grosvener siraitia. The pure traditional Chinese medicine particles can achieve the effects of moistening the lung to arrest a cough, stopping bleeding by astringency, relieving swelling and prompting tissue regeneration, removing blood stasis and reducing phlegm, descending qi and relieving coughs, killing insects and bacteria, clearing away heat and cooling blood, lubricating the intestines and expelling toxicant and the like, and the effects of blocking qi leakage and the like can be achieved through mucus mass energy contained in the pure traditional Chinese medicine particles. Repair is effectively carried out oriented to the pneumothorax focus, and the pure traditional Chinese medicine particles perform the functions of killing viruses and bacteria and diminishing inflammation, and relieving pain and stopping blood while blocking qi leakage until a patient is recovered. Normally, the pure traditional Chinese medicine particles take effect in three days, the patient is cured in a week, and the pure traditional Chinese medicine particles are convenient to take, fast in effect taking, not likely to cause relapse, safe, reliable and free of side effects.

Description

A kind of pure Chinese medicinal granule treating pneumothorax
Technical field
The present invention relates to the field of Chinese medicines, particularly relate to a kind of pure Chinese medicinal granule treating pneumothorax
Technical background
Pneumothorax refers to without, under wound or human factor situation, visceral layer pleura breaks, and gas enters the pathologic, physiologic situation that pleural space causes the long-pending gas in thoracic cavity and cause. lung steeps, by wind-puff under pleura, the person of being formed of breaking without obvious pathology and claims spontaneous pneumothorax; Spontaneous pneumothorax is mostly owing to wind-puff bubble under pleura breaks and causes, it is possible to see under pleura focus or cavity diabrosis, pleura is adhered band and the reason such as tears. Under pleura, wind-puff bubble can be congenital, it is possible to is acquired character; The former is congenital spandex dysplasia, and alveolus wall elasticity attenuation, forms pulmonary belb after expansion, be more common in the leptosomic type male sex, and chest X-ray is without obvious disease. The latter is relatively common on the basis of fiber focus after obstructive emphysema or inflammation. Bronchiole half blocks, distortion, produces flap valve mechanism and forms wind-puff bubble, and the wind-puff swollen bubble is because of nutrition, cycle penalty and regression sex change, so that breaks when coughing or intrapulmonic pressure increases. It is secondary to the pleuras such as chronic obstructive pulmonary disease pulmonary tuberculosis and lung disease person claims Secondary cases pneumothorax.
Western medical treatment principle comprise lie up general treatment, be vented therapy, prevent recurrence measure, operative therapy and prevention and treatment of complication etc. from allowing his clear-cutting forestland, current traditional Chinese medical science doctor trained in Western medicine does not all treat the special medicament of pneumothorax.
Summary of the invention
It is an object of the invention to solve the problems of the prior art, it is proposed to a kind of pure Chinese medicinal granule treating pneumothorax, can effectively pneumothorax focus be repaired, it is bitter until rehabilitation that blocking gas leakage carries out sterilization anti-inflammatory, analgesic hemostatic hypodynia simultaneously.
In order to realize above-mentioned purpose, a kind of pure Chinese medicinal granule treating pneumothorax that the present invention proposes, it is made up of following traditional Chinese medicine raw, and each Chinese medicine material group weight proportion is: Root of Lance Asiabell 240-260 gram, tuber of dwarf lilyturf 140-160 gram, tuber of stemona 90-110 gram, bletilla striata 70-90 gram, Radix Asparagi 140-160 gram, field thistle 140-160 gram, 70-90 gram, Radix Glycyrrhizae, Grosvenor Momordica 50-70 gram.
As preferably, Chinese medicine material group weight proportion is: Root of Lance Asiabell 250 grams, the tuber of dwarf lilyturf 150 grams, the tuber of stemona 100 grams, the bletilla striata 80 grams, Radix Asparagi 150 grams, field thistle 150 grams, 80 grams, Radix Glycyrrhizae, Grosvenor Momordica 60 grams.
As preferably, Chinese medicine material group weight proportion is: Root of Lance Asiabell 240 grams, the tuber of dwarf lilyturf 160 grams, the tuber of stemona 90 grams, the bletilla striata 90 grams, Radix Asparagi 140 grams, field thistle 160 grams, 70 grams, Radix Glycyrrhizae, Grosvenor Momordica 70 grams.
As preferably, Chinese medicine material group weight proportion is: Root of Lance Asiabell 260 grams, the tuber of dwarf lilyturf 140 grams, the tuber of stemona 110 grams, the bletilla striata 70 grams, Radix Asparagi 160 grams, field thistle 140 grams, 90 grams, Radix Glycyrrhizae, Grosvenor Momordica 50 grams. Effect of Chinese medicine in the present invention
Root of Lance Asiabell:Yin-nourishingMoistening lung, qi-restorativesLogical breast, apocenosisRemoving toxic substances, effect of benefit gas detumescence. It is usually used in spiritlessness and weakness, dizziness headache, lung carbuncle, acute mastitis, the swollen poison of sore furuncle, tonsillitis, scrofula, venomous snake bite etc.
The tuber of dwarf lilyturf: Yin-nourishing and body fluid promoting, moisten the lung and relieve the cough, clear away heart-fire relieving restlessness. Cure mainly consumption of body fluid caused by febrile disease, vexed, thirsty, dry throat lung heat, cough, pulmonary tuberculosis etc.
The tuber of stemona: moistening lung to lower QI cough-relieving, kills worm. Leak containing multiple alkaloid and mucus mass-energy gas shutoff. For new cough for a long time, pulmonary tuberculosis cough, Whooping cough; The honey tuber of stemona moistens the lung and relieve the cough. Cough for deficiency of Yin labor.
The bletilla striata: astringing to arrest bleeding, detumescence myogenic, mucous mass-energy envelope fills out lobe of the lung breakage. Spit blood for hemoptysis, traumatic hemorrhage, sore swollen toxin, chapped skin; Pulmonary tuberculosis hemoptysis, ulcer haemorrhage.
Radix Asparagi: enriching yin, moisturizes, and fire falls in clearing lung-heat. Mucous mass-energy gas shutoff leaks. Controlling fever due to yin deficiency, cough is spitted blood, and consumptive lung disease, lung carbuncle, swelling and pain in the throat, quenches one's thirst, constipation.
Field thistle: cooling blood for hemostasis, removing blood stasis to reduce swelling. For bleeding from five sense organs or subcutaneous tissue, spitting blood, hematuria, has blood in stool, metrostaxis, traumatic hemorrhage, carbuncle sore tumefacting virus etc.
Radix Glycyrrhizae: invigorate the spleen and benefit qi, expelling phlegm for arresting cough, relieving spasm to stop pain, clearing heat and detoxicating, coordinating the actions of various ingredients in a prescription.
Grosvenor Momordica: clearing heat and cooling blood, cough-relieving of promoting the production of body fluid, laxation toxin expelling, tender skin benefit effect such as face, moistening the lung and resolving the phlegm, treatment phlegm heat cough, swelling and pain in the throat, constipation, irritated all diseases of quenching one's thirst.
The preparation method of a kind of pure Chinese medicinal granule treating pneumothorax of the present invention
Selected above-mentioned raw materials, after decon dries or dries, is mixed in proportion and grinds to form 600 object powder. It is fired into dextrin with appropriate ground rice and water. Dextrin mixes with formula material powder again, mixes into moist shape thoroughly, is shaped through screw expeller, cuts into Chinese medicinal granule, puts into roller dryer limit rolling and dries, and temperature controls at 110 DEG C, roll 60 minutes Chinese medicinal granule finished product.
The useful effect of a kind of pure Chinese medicinal granule treating pneumothorax of the present invention:
Energy realization moistens the lung and relieve the cough, astringing to arrest bleeding, the effects such as detumescence myogenic, eliminate stagnation and dissolve phlegm, lower gas cough-relieving, pesticide-germicide, clearing heat and cooling blood, laxation toxin expelling, the effects such as contained mucus mass-energy energy gas shutoff leakage. Effectively pneumothorax focus being repaired, it is bitter until rehabilitation that blocking gas leakage carries out sterilization anti-inflammatory, analgesic hemostatic hypodynia simultaneously. General three days take effect, and within one week, cure, it may also be useful to convenience, instant effect, few recur, safe and reliable, have no side effect.
Instructions of taking:
Patient takes Chinese medicinal granule every day three times, each 30-40 grain, one after each meal.
Representative instance:
1, Mr. man original trachitis wine drunk at wedding feast in 68 years old, suffered from pneumothorax disease before 3 years, control institute to Zhejiang, the Hangzhou Second Academy and treat 15 days, everyday transfusion changed nearly 100,000 yuan without effect. Taking traditional Chinese medical science prescription after being introduced, pain disappears after one week, after serve on one week so far without repeatedly.
2, Lee classmate man's 17 years old height 1.85 meters is partially thin, and happiness is played ball, and feels costalgia of chest when once playing ball, and makes a definite diagnosis as pneumothorax through examination in hospital, and doctor says and can control can only rest without medicine at present, and anti-inflammatory of can infusing is protected from infection. 2nd day just starts to eat Chinese medicine, and taking three in order to upper prescription, to be posted on pain after the 2nd note light, and after three notes, pain disappears, after serve on again three note consolidate curative effect, so far without repeatedly.

Claims (4)

1. a kind of pure Chinese medicinal granule treating pneumothorax that the present invention proposes, it is made up of following traditional Chinese medicine raw, and each Chinese medicine material group weight proportion is: Root of Lance Asiabell 240-260 gram, tuber of dwarf lilyturf 140-160 gram, tuber of stemona 90-110 gram, bletilla striata 70-90 gram, Radix Asparagi 140-160 gram, field thistle 140-160 gram, 70-90 gram, Radix Glycyrrhizae, Grosvenor Momordica 50-70 gram.
2. a kind of pure Chinese medicinal granule treating pneumothorax according to claim 1, as preferably, Chinese medicine material group weight proportion is: Root of Lance Asiabell 250 grams, the tuber of dwarf lilyturf 150 grams, the tuber of stemona 100 grams, the bletilla striata 80 grams, Radix Asparagi 150 grams, field thistle 150 grams, 80 grams, Radix Glycyrrhizae, Grosvenor Momordica 60 grams.
3. a kind of pure Chinese medicinal granule treating pneumothorax according to claim 1, as preferably, Chinese medicine material group weight proportion is: Root of Lance Asiabell 240 grams, the tuber of dwarf lilyturf 160 grams, the tuber of stemona 90 grams, the bletilla striata 90 grams, Radix Asparagi 140 grams, field thistle 160 grams, 70 grams, Radix Glycyrrhizae, Grosvenor Momordica 70 grams.
4. a kind of pure Chinese medicinal granule treating pneumothorax according to claim 1, as preferably, Chinese medicine material group weight proportion is: Root of Lance Asiabell 260 grams, the tuber of dwarf lilyturf 140 grams, the tuber of stemona 110 grams, the bletilla striata 70 grams, Radix Asparagi 160 grams, field thistle 140 grams, 90 grams, Radix Glycyrrhizae, Grosvenor Momordica 50 grams.
CN201610137764.4A 2016-03-03 2016-03-03 Pure traditional Chinese medicine particles for treating pneumothorax Pending CN105617180A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610137764.4A CN105617180A (en) 2016-03-03 2016-03-03 Pure traditional Chinese medicine particles for treating pneumothorax

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610137764.4A CN105617180A (en) 2016-03-03 2016-03-03 Pure traditional Chinese medicine particles for treating pneumothorax

Publications (1)

Publication Number Publication Date
CN105617180A true CN105617180A (en) 2016-06-01

Family

ID=56032784

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610137764.4A Pending CN105617180A (en) 2016-03-03 2016-03-03 Pure traditional Chinese medicine particles for treating pneumothorax

Country Status (1)

Country Link
CN (1) CN105617180A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106177394A (en) * 2016-08-24 2016-12-07 曲先锋 A kind of medicine treating spontaneous pneumothorax and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104189509A (en) * 2014-09-12 2014-12-10 朱辉 Traditional Chinese medicine composition for spontaneous pneumothorax nursing

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104189509A (en) * 2014-09-12 2014-12-10 朱辉 Traditional Chinese medicine composition for spontaneous pneumothorax nursing

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106177394A (en) * 2016-08-24 2016-12-07 曲先锋 A kind of medicine treating spontaneous pneumothorax and preparation method thereof

Similar Documents

Publication Publication Date Title
CN101085198A (en) Internal-applied traditional Chinese medicine composition for treating chronic pharyngitis
CN103169885A (en) Traditional Chinese medicine composition for treating infantile asthma
CN105617180A (en) Pure traditional Chinese medicine particles for treating pneumothorax
CN107582702A (en) Medicine Wax composition for traditional Chinese medical science wax therapy and preparation method thereof
CN106581585A (en) Medicine composition for treating gastric ulcer
CN113144141A (en) A Chinese medicinal composition for treating cough
CN104958395A (en) Traditional Chinese medicine composition for treating cold-with-dampness type cough
CN102133293B (en) Medicament for treating rhinitis and preparation method thereof
CN104721573A (en) Traditional Chinese medicinal composition for treating phlegm-damp type chronic bronchitis
CN101810838A (en) Cold cough patch
CN105168945A (en) External ointment for promoting fracture healing and preparation method of external ointment
CN106110244A (en) Powder for relieving cough and asthma
CN105477625A (en) Dust adsorption and removal Chinese herbal medicine preparation and preparation method thereof
CN107753909A (en) A kind of endo-medicine and preparation method for treating infantile cough
CN107343922A (en) A kind of endo-medicine for treating chronic bronchitis and preparation method thereof
CN104547566A (en) Rhinitis treating powder capable of refreshing brain, refreshing lung, relieving sore throat and alleviating pain and preparation method of powder
CN104189815A (en) Traditional Chinese medicine preparation for treating children bronchial asthma
CN108721458A (en) A kind of Chinese medicine preparation for treating tracheitis
CN102406806B (en) Traditional Chinese medicinal powder for treating obstructive disease and embolic disease of lung and preparation method thereof
CN107789447A (en) A kind of Chinese medicine composition and preparation method for being used to treat bronchial astehma
CN107596310A (en) A kind of ointment medicine for treating tracheitis and preparation method thereof
CN107714870A (en) A kind of Chinese medicine composition that can effectively treat bronchial astehma
CN108721459A (en) A kind of Chinese medicine preparation for treating palpitaition
CN108030843A (en) A kind of Chinese medicine for treating pulmonary emphysema
CN107519439A (en) It is a kind of to be used to treat endo-medicine of infantile cough and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20161109

Address after: Jiang new village in Zhejiang Province, Changxing County Town, No. 74 pheasant

Applicant after: Changxing County Dongfang traditional Chinese Medicine Research Institute

Address before: Jiang new village 313102 Zhejiang province Changxing County pheasant town No. 74

Applicant before: Liu Xiangqiu

RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20160601